Open access
Aug 2026
Therapeutic NAMPT inhibition reveals a targetable metabolic vulnerability in neuroblastoma
NB is identified as a highly NAMPT inhibitor-sensitive pediatric solid tumor and NAMPT-dependent NAD + biosynthesis as a targetable metabolic vulnerability in this disease is established.
Sophia Varriano, Amy Yu, Abantika Chakraborty et al.
· Journal of Experimental &... · 0 citations